HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Choleretic effects of alpha-iridodiol on experimentally induced intrahepatic cholestasis.

Abstract
When a lymphokine, the cholestatic factor, was intravenously injected into rats through a mesenteric vein, a remarkable reduction in bile flow was observed. Using this experimentally induced intrahepatic cholestasis model, we studied the choleretic effects of alpha-iridodiol, an iridoid compound. When alpha-iridodiol was administered 30 min before, at the same time, or 30 min after injection of the cholestatic factor, the reductions in bile flow and bile acid excretion were significantly inhibited. Remarkable choleretic effects were also noted when it was administered to normal rats. These results suggested that alpha-iridodiol may be effective in the treatment of intrahepatic cholestasis.
AuthorsY Mizoguchi, C Sakagami, Y Ichikawa, K Kobayashi
JournalPlanta medica (Planta Med) Vol. 58 Issue 5 Pg. 394-7 (Oct 1992) ISSN: 0032-0943 [Print] Germany
PMID1470661 (Publication Type: Journal Article)
Chemical References
  • Cholagogues and Choleretics
  • Cyclopentanes
  • Iridoids
  • iridodiol
Topics
  • Animals
  • Cholagogues and Choleretics (pharmacology)
  • Cholestasis, Intrahepatic (drug therapy)
  • Cyclopentanes (chemistry, pharmacology)
  • Guinea Pigs
  • Iridoids
  • Molecular Structure
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: